However, the company through its partner AstraZeneca has reached out to the European Medicines Agency in May seeking to consider SII as an alternate manufacturing site for the production of Covishield which is identical to AstraZenaca#39;s Vaxzevria.Serum Institute hasn#39;t applied for full marketing approval of Covishield in Europe: Sources
However, the company through its partner AstraZeneca has reached out to the European Medicines Agency in May seeking to consider SII as an alternate manufacturing site for the production of Covishield which is identical to AstraZenaca#39;s Vaxzevria.
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment